Pharmacoeconomic Studies
Retrospective studies using administrative claims data to understand aspects of health care cost and utilization for patients with iron deficiency anemia.
This section includes links to Pharmacosmos sponsored- publications and selected Pharmacosmos posters. Information contained in these publications may include information that is inconsistent with the FDA approved use of product(s). Pharmacosmos does not recommend the use of its products in a manner that is inconsistent with FDA-approved labeling. Additionally, the content contained in this section is subject to congress copyright permissions.
Apr 23-25, 2025 I NCODA (Poster)
Single-Dose Ferric Derisomaltose had the Highest Adherence Among Intravenous Iron Therapy in a National Community Oncology Network Real-World Analysis
Chang M, Mulherin B, Patel T, et al.
** Coming Soon **
Mar 31-Apr 3, 2025 I AMCP (Poster)
Impact of Geographic Location on Intravenous Iron Treatment Adherence in Urban, Rural, and Super Rural Regions:
Single-dose IV iron ferric derisomaltose demonstrated the highest adherence rate that was not affected by the region
Shatzel J, Polson M, Novak J
May 5-8, 2024 I ISPOR (Poster)
Impact of Covid-19 Pandemic on Iv Iron Cost and Utilization in Commercially-Insured Patients with Iron Deficiency Anemia
Polson M, Winegar B, Kidd S
May 5-8, 2024 I ISPOR (Poster)
Enhancing Oncology Model: Discordance Among Patients Using Intravenous Iron in the US
Ratnam S, Polson M
April 15-18, 2024 I AMCP (Poster)
Intravenous Iron Treatment Considerations in
Patients with Non-Dialysis Dependent Chronic Kidney Disease
Upadhyay A, Polson M
April 15-18, 2024 I AMCP (Poster)
Management of Iron Deficiency Anemia In Oncology:
Intravenous Iron Discordance in Cancer Patients
Page RD, Narang M, Polsen M
July 2023 I JMCP
Financial Burden Associated with Discordance to Intravenous Iron Therapies in US Patients with Iron Deficiency Anemia
Polson MK, Bahrain H, Ogden JF et al.
March 29-April 1, 2022 I AMCP (Poster)
Financial Burden Associated with Discordance to Intravenous Iron Therapies in US Patients with Iron Deficiency Anemia
Polson M, Utkina K, Bucco R, et al.
March 21-April 24, 2022 I AMCP (Poster)
Evaluation of Discordance and Economic Outcomes Among Patients Using Intravenous Iron in the US
Hull M, Doshi R, DeKoven M, et al.